If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE
  |
|
 | | Good Morning Pan, | THU 02 Dec 2010 | | | |  |  | |  | |  | |  |  |  |  |  | December 02, 2010 12:20 AM ET  | CHICAGO (Reuters) - U.S. researchers are closing in on an accurate test for autism, a finding that could lead to earlier diagnosis and treatment.
 | |  |  | December 01, 2010 07:09 PM ET  | LONDON (Reuters) - Scientists have developed a new range of tests that allow them to track the progression of Huntington's disease long before symptoms appear and should aid the development of drugs for the incurable inherited disease.
 | |  |  | December 02, 2010 07:37 AM ET  | NEW YORK (Reuters) - Americans are slowly making their way back to the doctor's office after many months of skimping on medical care, holding off on everything from routine visits to hip replacements.
 | |  |  |  | December 01, 2010 07:36 PM ET  | NEW YORK (Reuters) - Johnson & Johnson's consumer-product distress worsened on Wednesday as the company recalled 12 million bottles of over-the-counter Mylanta and almost 85,000 bottles of its AlternaGel liquid antacid.
 | |  |  | December 01, 2010 11:45 PM ET  | SINGAPORE (Reuters) - Bayer AG said on Thursday it had entered into five projects with scientists in Singapore to work on earlier diagnosis and treatment of cancers that are most prevalent in Asia.
 | |  |  | December 01, 2010 05:52 PM ET  | WASHINGTON (Reuters) - Democratic senators criticized low-cost, bare-bones health insurance plans on Wednesday, saying the plans designed for low-wage workers can be worse than no coverage at all.
 | |  |  |  | December 01, 2010 05:27 PM ET  | WASHINGTON (Reuters) - The U.S. military's "Don't Ask, Don't Tell" policy for gays helps spread disease and puts service members' health at risk, a commentary by a doctor in the New England Journal of Medicine said Wednesday.
 | |  |  |  | December 01, 2010 05:31 PM ET  | NEW YORK (Reuters Health) - The number of Canadians having blocked heart arteries opened with a non-surgical procedure more than doubled between 1994 and 2005, mirroring trends seen in the U.S., Europe and elsewhere, according to a new study.
 | |  |  |  | December 01, 2010 05:41 PM ET  | NEW YORK (Reuters) - The U.S. Food and Drug Administration declined to approve an experimental epilepsy drug from GlaxoSmithKline and Valeant Pharmaceuticals International, the companies said on Wednesday, marking another delay for the anti-seizure medicine.
 | |  |  |  | December 02, 2010 07:35 AM ET  | Corrects that Johnson & Johnson makes Risperdal, not Eli Lilly, in para 10 of story posted posted on Nov 10, 2010
 | | | | | 

| | | |
No comments:
Post a Comment